Novartis: set to make 1000 redundancies in Switzerland

(CercleFinance.com) - Novartis today announced its intention to continue adapting its manufacturing network and service activities.


The group plans to continue adjusting its industrial facilities to its product portfolio, which is trending towards a reduction in the number of large-series products in order to focus on innovative specialised and personalised medicines.

In Switzerland, the group expects to make net layoffs of approximately 1000 posts in Basel, Schweizerhalle, Stein and Locarno by 2022. This downsizing could reach 700 by 2022, mainly at the company's Basel campus.



Copyright (c) 2018 CercleFinance.com. All rights reserved.